Peer-reviewedLicence not statedJournal of the American Heart Association12 Nov 2026

Safety and Efficacy of Apixaban Therapy for Coronary Artery Aneurysms After Kawasaki Disease

Annette L. Baker¹
Kimberlee Gauvreau^1,2
Francesca Sperotto^1,2
Amy Hellinger¹
Ryan J. Williams^1,2
Sarah D. de Ferranti^1,2
Audrey Dionne^1,2
Kevin G. Friedman^1,2
MaryBeth F. Son^2,1
Paul Esteso^1,2
Thomas J. Giorgio¹
Veronique C. Wright¹

3 more authors

Sunil J. Ghelani^1,2
Christina J. VanderPluym^1,2
Jane W. Newburger^1,2

¹Boston Children's Hospital
²Harvard Medical School

Open at source DOI Cite

Risk Factors for Coronary Artery Aneurysms in Children With Kawasaki Disease
Shoko Yamazaki, Koichi Miyata, Xiaoying Sun +6
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease9 Sep 2026Peer-reviewedCC BY-NC-ND 4.0Full textObstetrics, gynaecology & paediatricsPMC
Clinical outcomes of rivaroxaban and warfarin for anticoagulation in children with giant coronary artery aneurysms after Kawasaki disease
Penghui Yang, Jinlin Wu, Lei Liu +9
Pediatric Rheumatology10 Aug 2026Peer-reviewedCC BY-NC-ND 4.0Full textObstetrics, gynaecology & paediatricsPMC
Anatomical distribution pattern of coronary artery lesions in Kawasaki disease and the prognostic value of dynamic Z-scores for recovery time: a retrospective cohort study
Yuhui Zhang, Yaowen Sun, Peipei Gu +10
Frontiers in pediatrics12 Nov 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
Early efficacy of oral lipid lowering therapy in achieving LDL-C targets following acute coronary syndrome: A real-world observational study.
Ambresh Kumar Gautam, Sudesh Prajapathi, Abhishek Singh +11
American heart journal plus : cardiology research and practice6 Oct 2026Peer-reviewedCC BY-NCFull textSurgery & anaesthesiaEurope PMC
Comparative efficacy and safety of de-escalation, abbreviation, and standard potent P2Y₁₂ inhibitor-based dual antiplatelet therapy strategies after acute coronary syndrome: a network meta-analysis.
Yee-Jen Wu, Hung-Ju Lin, Yi-Chen Chou +2
European heart journal open1 Sep 2026Peer-reviewedCC BY-NCFull textCardiovascular medicineEurope PMCPMC

Cite

BibTeX RIS

BibTeX

@article{baker2026safety,
  title = {{Safety and Efficacy of Apixaban Therapy for Coronary Artery Aneurysms After Kawasaki Disease}},
  author = {Annette L. Baker and Kimberlee Gauvreau and Francesca Sperotto and Amy Hellinger and Ryan J. Williams and Sarah D. de Ferranti and Audrey Dionne and Kevin G. Friedman and MaryBeth F. Son and Paul Esteso and Thomas J. Giorgio and Veronique C. Wright and Sunil J. Ghelani and Christina J. VanderPluym and Jane W. Newburger},
  journal = {Journal of the American Heart Association},
  year = {2026},
  month = nov,
  doi = {10.1161/jaha.126.049822},
  url = {https://www.ahajournals.org/doi/10.1161/JAHA.126.049822},
}

RIS

TY  - JOUR
TI  - Safety and Efficacy of Apixaban Therapy for Coronary Artery Aneurysms After Kawasaki Disease
AU  - Annette L. Baker
AU  - Kimberlee Gauvreau
AU  - Francesca Sperotto
AU  - Amy Hellinger
AU  - Ryan J. Williams
AU  - Sarah D. de Ferranti
AU  - Audrey Dionne
AU  - Kevin G. Friedman
AU  - MaryBeth F. Son
AU  - Paul Esteso
AU  - Thomas J. Giorgio
AU  - Veronique C. Wright
AU  - Sunil J. Ghelani
AU  - Christina J. VanderPluym
AU  - Jane W. Newburger
PY  - 2026
DA  - 2026/11/12
JO  - Journal of the American Heart Association
DO  - 10.1161/jaha.126.049822
UR  - https://www.ahajournals.org/doi/10.1161/JAHA.126.049822
SN  - 2047-9980
ER  -

Related

Cite